$HSTM
HEALTHSTREAM INC Stock $hstm

$hstm Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000143774924013221 Filed on April 25, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$71.56M	$72.76M
YoY Change	3.41%	5.53%
Cost Of Revenue	$23.74M	$24.62M
YoY Change	0.73%	3.19%
Gross Profit	$47.82M	$48.14M
YoY Change	4.79%	6.77%
Gross Profit Margin	66.83%	66.17%
Selling, General & Admin	$20.96M	$17.09M
YoY Change	19.3%	-4.52%
% of Gross Profit	43.83%	35.49%
Research & Development	$12.08M	$12.03M
YoY Change	9.47%	3.01%
% of Gross Profit	25.25%	24.99%
Depreciation & Amortization	$10.37M	$10.34M
YoY Change	1.45%	4.13%
% of Gross Profit	21.69%	21.47%
Operating Expenses	$43.41M	$12.03M
YoY Change	4.29%	3.01%
Operating Profit	$4.411M	$5.690M
YoY Change	10.05%	96.82%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$889.0K	$853.0K
YoY Change	80.69%	241.2%
Pretax Income	$5.300M	$6.543M
YoY Change	17.78%	108.31%
Income Tax	$1.132M	$1.300M
% Of Pretax Income	21.36%	19.87%
Net Earnings	$4.168M	$5.227M
YoY Change	0.85%	99.28%
Net Earnings / Revenue	5.82%	7.18%
Basic Earnings Per Share	$0.14	$0.17
Diluted Earnings Per Share	$0.14	$0.17
COMMON SHARES
Basic Shares Outstanding	30.40M	30.30M
Diluted Shares Outstanding	30.53M	30.42M

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$83.00M	$83.67M
YoY Change	48.31%	42.65%
Cash & Equivalents	$46.13M	$52.41M
Short-Term Investments	$36.87M	$31.27M
Other Short-Term Assets	$19.92M	$2.094M
YoY Change	-5.92%	-74.49%
Inventory
Prepaid Expenses
Receivables	$36.20M	$39.64M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$139.1M	$147.4M
YoY Change	17.88%	17.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$30.72M	$12.54M
YoY Change	-14.51%	-14.65%
Goodwill	$191.0M	$191.1M
YoY Change	-0.2%	-0.02%
Intangibles
YoY Change
Long-Term Investments	$4.053M	$4.103M
YoY Change	-5.24%	-6.56%
Other Assets	$36.04M	$782.0K
YoY Change	21.82%	18.13%
Total Long-Term Assets	$360.4M	$364.2M
YoY Change	-4.0%	-3.66%
TOTAL ASSETS
Total Short-Term Assets	$139.1M	$147.4M
Total Long-Term Assets	$360.4M	$364.2M
Total Assets	$499.6M	$511.6M
YoY Change	1.23%	1.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$25.00M	$5.313M
YoY Change	12.86%	-73.6%
Accrued Expenses	$15.00M	$16.78M
YoY Change	186.55%	156.79%
Deferred Revenue	$86.89M	$98.27M
YoY Change	6.26%	4.15%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$111.9M	$126.1M
YoY Change	2.5%	4.19%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$22.89M	$2.253M
YoY Change	-12.71%	2.64%
Total Long-Term Liabilities	$22.89M	$2.253M
YoY Change	-12.71%	2.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$111.9M	$126.1M
Total Long-Term Liabilities	$22.89M	$2.253M
Total Liabilities	$150.3M	$128.3M
YoY Change	-1.64%	4.16%
SHAREHOLDERS EQUITY
Retained Earnings	$100.1M	$96.75M
YoY Change	17.12%	17.88%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$349.2M	$344.9M
YoY Change
Total Liabilities & Shareholders Equity	$499.6M	$511.6M
YoY Change	1.23%	1.68%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$4.168M	$5.227M
YoY Change	0.85%	99.28%
Depreciation, Depletion And Amortization	$10.37M	$10.34M
YoY Change	1.45%	4.13%
Cash From Operating Activities	$6.451M	$20.94M
YoY Change	30.38%	1.93%
INVESTING ACTIVITIES
Capital Expenditures	$6.705M	$742.0K
YoY Change	7.35%	-15.59%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	-$5.206M	$641.0K
YoY Change	-74.14%	-107.57%
Cash From Investing Activities	-$11.91M	-$7.120M
YoY Change	-54.85%	-57.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-857.0K	-$1.704M
YoY Change	-44.35%	115.42%
NET CHANGE
Cash From Operating Activities	6.451M	$20.94M
Cash From Investing Activities	-11.91M	-$7.120M
Cash From Financing Activities	-857.0K	-$1.704M
Net Change In Cash	-6.317M	$12.07M
YoY Change	-72.5%	329.22%
FREE CASH FLOW
Cash From Operating Activities	$6.451M	$20.94M
Capital Expenditures	$6.705M	$742.0K
Free Cash Flow	-$254.0K	$20.20M
YoY Change	-80.43%	2.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	901000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	781000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20459000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19503000	usd
CY2024Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	132960000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	127009000	usd
CY2024Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30398000
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30398000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30298000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30298000
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	200000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	usd
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.028
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.025
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	000-27701
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	TN
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	62-1443555
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	500 11th Avenue North, Suite 1000
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Nashville
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37203
CY2024Q1	dei	City Area Code CityAreaCode	615
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	301-3100
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock (Par Value $0.00)
CY2024Q1	dei	Trading Symbol TradingSymbol	HSTM
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30397886
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52407000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	40333000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	31265000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	30800000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39635000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	34346000	usd
CY2024Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	4419000	usd
CY2023Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	4100000	usd
CY2024Q1	us-gaap	Prepaid Royalties PrepaidRoyalties	10960000	usd
CY2023Q4	us-gaap	Prepaid Royalties PrepaidRoyalties	10202000	usd
CY2024Q1	hstm	Prepaid Software Maintenance And Subscriptions PrepaidSoftwareMaintenanceAndSubscriptions	6609000	usd
CY2023Q4	hstm	Prepaid Software Maintenance And Subscriptions PrepaidSoftwareMaintenanceAndSubscriptions	7397000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	2094000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3032000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	147389000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	130210000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12537000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13005000	usd
CY2024Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	41118000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	40643000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19483000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	20114000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	191072000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	191379000	usd
CY2024Q1	hstm	Contract With Customer Asset Sales Commission Noncurrent ContractWithCustomerAssetSalesCommissionNoncurrent	30671000	usd
CY2023Q4	hstm	Contract With Customer Asset Sales Commission Noncurrent ContractWithCustomerAssetSalesCommissionNoncurrent	31700000	usd
CY2024Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	4103000	usd
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	4134000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	782000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	726000	usd
CY2024Q1	us-gaap	Assets Assets	511605000	usd
CY2023Q4	us-gaap	Assets Assets	499942000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	5313000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7465000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16776000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	22717000	usd
CY2024Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	5713000	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	4556000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	98268000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	83623000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	126070000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	118361000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	16868000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	16132000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2076000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2169000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	19484000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	20247000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2253000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2281000	usd
CY2024Q1	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	249280000	usd
CY2023Q4	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	249075000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	96746000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	92368000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1172000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-691000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	344854000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	340752000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	511605000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	499942000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	72760000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68946000	usd
CY2024Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	24617000	usd
CY2023Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	23856000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12032000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11680000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11773000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11728000	usd
CY2024Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	8312000	usd
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	8865000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10336000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9926000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	67070000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	66055000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	5690000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	2891000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	853000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	250000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6543000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3141000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1316000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	518000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	5227000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2623000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30313000
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30591000
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30418000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30659000
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.028
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.025
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	5227000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2623000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-476000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-33000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-5000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-481000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-35000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4746000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2588000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	340752000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	5227000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-481000	usd
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	849000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1060000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-855000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	344854000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	334064000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2623000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-35000	usd
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	767000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	945000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-791000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	336039000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	5227000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2623000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10336000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9926000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1060000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	945000	usd
CY2024Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	2957000	usd
CY2023Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	2712000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	174000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	209000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	771000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	800000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-31000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-127000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	346000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	85000	usd
CY2024Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	5782000	usd
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	4787000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Royalties IncreaseDecreaseInPrepaidRoyalties	758000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Royalties IncreaseDecreaseInPrepaidRoyalties	1889000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-959000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-482000	usd
CY2024Q1	hstm	Increase Decrease In Deferred Commissions IncreaseDecreaseInDeferredCommissions	1928000	usd
CY2023Q1	hstm	Increase Decrease In Deferred Commissions IncreaseDecreaseInDeferredCommissions	1490000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	56000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-147000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-7416000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4773000	usd
CY2024Q1	us-gaap	Increase Decrease In Royalties Payable IncreaseDecreaseInRoyaltiesPayable	1157000	usd
CY2023Q1	us-gaap	Increase Decrease In Royalties Payable IncreaseDecreaseInRoyaltiesPayable	1090000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	14552000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	14504000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20938000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20541000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-0	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	6621000	usd
CY2024Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	14000000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	1000000	usd
CY2024Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	14124000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	2850000	usd
CY2024Q1	hstm	Proceeds From The Sale Of Nonmarketable Equity Investments ProceedsFromTheSaleOfNonmarketableEquityInvestments	765000	usd
CY2023Q1	hstm	Proceeds From The Sale Of Nonmarketable Equity Investments ProceedsFromTheSaleOfNonmarketableEquityInvestments	0	usd
CY2024Q1	us-gaap	Payments For Software PaymentsForSoftware	7019000	usd
CY2023Q1	us-gaap	Payments For Software PaymentsForSoftware	7566000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	742000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	879000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7120000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16916000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	855000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	791000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	849000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	-0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1704000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-791000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-40000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-21000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	12074000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2813000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	40333000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	46023000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	52407000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	48836000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	72760000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68946000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	200000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	40000000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	39100000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	514000000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.44	pure
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2024Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	3000000	usd
CY2023Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	2700000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1300000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	500000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.20	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.16	pure
CY2024Q1	hstm	Income Tax Expense Benefit Discrete Adjustments IncomeTaxExpenseBenefitDiscreteAdjustments	-17000	usd
CY2024Q1	hstm	Income Tax Expense Benefit Stockbased Awards IncomeTaxExpenseBenefitStockbasedAwards	-129000	usd
CY2024Q1	hstm	Reserve For Uncertain Tax Position ReserveForUncertainTaxPosition	112000	usd
CY2023Q1	hstm	Income Tax Expense Benefit Discrete Adjustments IncomeTaxExpenseBenefitDiscreteAdjustments	-53000	usd
CY2023Q1	hstm	Income Tax Expense Benefit Stockbased Awards IncomeTaxExpenseBenefitStockbasedAwards	-133000	usd
CY2023Q1	hstm	Reserve For Uncertain Tax Position ReserveForUncertainTaxPosition	80000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1060000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	945000	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	176000
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	268000
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	5227000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2623000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30313000
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30591000
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	105000
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	68000
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30418000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30659000
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2024Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	31261000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	6000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	31265000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	30791000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	10000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	30800000	usd

Files In Submission

Name	View Source	Status
0001437749-24-013221-index-headers.html	Edgar Link	pending
0001437749-24-013221-index.html	Edgar Link	pending
0001437749-24-013221.txt	Edgar Link	pending
0001437749-24-013221-xbrl.zip	Edgar Link	pending
ex_637738.htm	Edgar Link	pending
ex_637739.htm	Edgar Link	pending
ex_637740.htm	Edgar Link	pending
ex_637741.htm	Edgar Link	pending
ex_654044.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hstm-20240331.xsd	Edgar Link	pending
hstm20240331_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hstm-20240331_cal.xml	Edgar Link	unprocessable
hstm-20240331_def.xml	Edgar Link	unprocessable
hstm20240331_10q_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
hstm-20240331_lab.xml	Edgar Link	unprocessable
hstm-20240331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HSTM
HEALTHSTREAM INC Stock $hstm

2024 Q2 Form 10-Q Financial Statement

#000143774924013221 Filed on April 25, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HSTM HEALTHSTREAM INC Stock $hstm

2024 Q2 Form 10-Q Financial Statement

#000143774924013221 Filed on April 25, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HSTM
HEALTHSTREAM INC Stock $hstm